Navigation Links
Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
Date:12/13/2007

SAN ANTONIO, Texas, Dec. 13 /PRNewswire/ -- Kathy S. Albain, MD, of Loyola University Chicago, presented new data showing for the first time the predictive value of the 21-gene Recurrence Score (RS) assay in patients with node-positive breast cancer. The Breast Cancer Intergroup of North America trial conducted by the Southwest Oncology Group (SWOG 8814) originally showed that patients treated with 6 cycles of chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil followed by 5 years of tamoxifen (CAF-T) had superior disease-free survival (DFS) and overall survival (OS) compared with patients treated with tamoxifen alone. This RS assay was performed on the breast cancer tumor specimens collected on this trial, and measured the same groups of genes already in use to predict outcomes and chemotherapy benefit in lymph node-negative disease. Up until this study, standard practice was to give chemotherapy to women with positive nodes. This study sought to determine if the RS assay would be useful to predict who might avoid chemotherapy.

Dr Albain's group first showed that the RS is prognostic for 10-year DFS and OS in patients treated with tamoxifen alone. They then compared DFS in patients treated with tamoxifen versus patients treated with CAF-T across RSs. They found that there was a large and significant benefit in DFS over 10 years from adding CAF in patients with a high RS. In contrast, there was no benefit in patients with a low RS. Interaction between CAF benefit and the linear RS was significant overall and in the first 5 years. There was a strong carryover benefit of CAF in high RSs out to 10 years, but no effect whatsoever in low RSs long term. This interaction of RS with treatment effect was true in greater than or equal to 4 positive nodes and 1 to 3 positive nodes.

In summary, this work demonstrates that: (1) a very strong benefit from chemotherapy with CAF is predicted when the RS is high, and that (2) a low RS may define
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. The next generation: nanomagnets could replace semiconductors
2. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
3. Nanotech could make solar energy as easy and cheap as growing grass
4. Bone-growing nanomaterial could improve orthopaedic implants
5. Stem Cell Breakthrough Could End Human Embryonic Experimentation
6. FED-TVs with carbon nanotube technology could supersede plasma and LCD flat screens
7. Blue dye could hold the key to super processing power
8. ORNL super water repellent could cause big wave in market
9. Tethered to chip, energy supply that drives sperm could power nanobot
10. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
11. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire/--PearlTherapeuticsInc.,abiophar...hetreatmentofchronicrespiratorydiseases,todayannou...fDirectors.Mr.Rosenhas25yearsofexperienceinthephar...olesatGileadSciencesandALZACorporation.Hisappointm...x. ,, "Howiebringsawealthofproductdevelopment,c...
(Date:11/20/2009)...20 Veridiam (www.veridiam.com) won...pany category at the 2009 Workplace Excellence Awa...iety for Human Resources Management and recognize ...es. ,, Veridiam was one of nine winners, select..., honored at the recent awards ceremony. San Diego...
(Date:11/20/2009).... 20 Cell Therapeutics, ...that the Ninth Circuit Court of Appeals reversed a...ld be allowed to pursue all of its claims against ...ict Court for trial. CTI filed a complaint agains...sement consultant for CTI,s product TRISENOX, in 2...
(Date:11/19/2009)...19 Danish Prince Joachim inaugurat...plant in Kalundborg, Denmark, on Wednesday, Novemb...d largest 2nd generation ethanol demonstration bio...d in the plant,s innovative process for converting...as the first to market with commercial enzymes for...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...Principle with U.S. Attorney,s Office; ...gain Increases 2007 Earnings Guidance and Introduc...Inc. (Nasdaq:,CEPH) today reported third quarter 2...sales of $457.2 million for the third quarter of 2...dance. Basic loss per common,share for the third q...
...c and the Aflac Cancer Center for partne...MBUS, Ga., Nov. 8 Last night, the relationship th...e Aflac Cancer Center and,Blood Disorders Service ...th a U.S. Chamber of Commerce,s Corporate Citizens... television personality, Ed McMahon in,Washington,...
...dical,Innovations (Amex: IMA ) today announced th... Inc. for the worldwide manufacture and,distributi...um, the primary,causative agent of tuberculosis. T...odies for the detection of Lipoarabinomannan (LAM)...rrent mycobacterial infection,(including Tuberculo...
Other Biology Technology:Cephalon Announces Strong Third Quarter Financial Results 2Cephalon Announces Strong Third Quarter Financial Results 3Cephalon Announces Strong Third Quarter Financial Results 4Cephalon Announces Strong Third Quarter Financial Results 5Cephalon Announces Strong Third Quarter Financial Results 6Cephalon Announces Strong Third Quarter Financial Results 7Cephalon Announces Strong Third Quarter Financial Results 8Cephalon Announces Strong Third Quarter Financial Results 9Cephalon Announces Strong Third Quarter Financial Results 10Cephalon Announces Strong Third Quarter Financial Results 11Cephalon Announces Strong Third Quarter Financial Results 12Cephalon Announces Strong Third Quarter Financial Results 13Cephalon Announces Strong Third Quarter Financial Results 14Cephalon Announces Strong Third Quarter Financial Results 15Cephalon Announces Strong Third Quarter Financial Results 16Cephalon Announces Strong Third Quarter Financial Results 17Cephalon Announces Strong Third Quarter Financial Results 18Aflac Honored with Corporate Citizenship Award 2Aflac Honored with Corporate Citizenship Award 3Inverness - Chemogen Establish Exclusive License for TB Antibodies 2
(Date:11/22/2009)...ember 18, 2009 -- A butterfly,s proboscis looks li...-- but it works more like a paper towel, according...pes to borrow the tricks of this piece of insect a...uid inside of cells. , Kornev will present his w...erican Physical Society,s (APS) Division of Fluid ...
(Date:11/21/2009)...vember 20,2009 / b3c newswire / - KINAXO Biotech...cing round, gaining two new investors in the compa...NAXO reports that Jrgen Schumacher has been electe..., KINAXO shareholders Axel Ullrich, Hellmut Kirc...tutional investors Mountain Partners, BioM, High-T...
(Date:11/20/2009)...ve all read studies about the health benefits of h...e molecular level, where amino acids known as cyst...le than when paired up with other cysteines. , N...ng with colleagues in Belgium, have discovered a n...es. The research appears in the Nov. 20 issue of t...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Saving the single cysteine: New antioxidant system found 2United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 1United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 1Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 3Two Treatments Equally Effective for Chronic Pelvic Pain 55939 1Two Treatments Equally Effective for Chronic Pelvic Pain 55939 2
...howed that a fruit fly gene is crucial for determi...nd how the transformation initially proceeds. Unde...how adorable children become surly teenagers. , Wh...ely begin metamorphosis ?maturation from an immatu...st genetic mutation found to cause early maturatio...
...e University of North Carolina Hospitals arrived i...in and a glowing track record in helping to repair...blocked coronary arteries and perform gastric bypa...l is a robotic machine, the da Vinci Surgical Syst...tly is the only gynecological oncology program in ...
...ink between two biochemical pathways that plants u...s that scientists have long believed worked indepe...ys of immunity work may one day help researchers b...thogens, said David Mackey, the study,s lead autho...rop science at Ohio State University . , He and h...
Other Biology News:MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 2MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 3MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 4Screen all at risk for HIV, plus pregnant women 2Screen all at risk for HIV, plus pregnant women 3Study: Plants use dual defense system to fight pathogens 2
PIP Array from Echelon Biosciences Inc.
...rf Reference Series 2000 Pipette is a synonym for ... robust design, and superior operating comfort. It...e the measuring stroke and blow-out as well as eje...p" system ensures utmost accuracy and precision. E...
Goat Anti-Human STMN2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human PAEP Monoclonal Antibody, Unconjugated, Clone 6G2 from Novus Biologicals
Biology Products: